The Venture Codex Logo

The Venture Codex

Global BioAccess Fund

880 3rd Avenue, 16th Floor, New York, 10022, United States

Overview

Invests in transformative technologies for unmet medical needs.

Founded

2021

Deals · 12mo

1

Links

WebsiteLinkedIn

Stage focus

Series B

Geographic focus

Denmark
United States

Sector focus

Financial Services
Medical
Medical Device
Venture Capital

Investment portfolio

7rounds
NAMEDATESIZE
Altay Therapeutics
Oct 2026Participated
$37 MSeries A
Cartography Biosciences
Oct 2025Participated
$67 MSeries B
Nuvig Therapeutics
Dec 2024Participated
$161 MSeries B
Vittoria Biotherapeutics
Nov 2024Participated
$10 MOther Equity
ShiraTronics
Oct 2024Participated
$66 MSeries B
Odyssey Therapeutics
Dec 2023Participated
$101 MSeries C
Acesion Pharma
Sep 2023Participated
$48 MSeries B
Altay Therapeutics
Oct 2026Participated
$37 MSeries A
Cartography Biosciences
Oct 2025Participated
$67 MSeries B
Nuvig Therapeutics
Dec 2024Participated
$161 MSeries B
Vittoria Biotherapeutics
Nov 2024Participated
$10 MOther Equity
ShiraTronics
Oct 2024Participated
$66 MSeries B
Odyssey Therapeutics
Dec 2023Participated
$101 MSeries C
Acesion Pharma
Sep 2023Participated
$48 MSeries B
7
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Global BioAccess Fund: 7 funding rounds are recorded in the selected participation categories.All available history.
Global BioAccess Fund: 7 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A01
Series B04
Series C+01
Other Equity01

Monthly Deal Activity

Global BioAccess Fund: 7 deals are recorded across 38 months.All available history.
Global BioAccess Fund: 7 deals are recorded across 38 months. All available history
MonthDeals
Sep '231
Oct '230
Nov '230
Dec '231
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '241
Nov '241
Dec '241
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '251
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '261

Sector Breakdown

Global BioAccess Fund: Health & Life Sciences is the largest displayed sector by deal count (7 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Global BioAccess Fund: Health & Life Sciences is the largest displayed sector by deal count (7 deals). All available history
SectorDeals
Health & Life Sciences7
Data, Analytics & IT1
Space & Frontier Tech1

Deal Size Distribution

Global BioAccess Fund: 7 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Global BioAccess Fund: 7 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M1
$25M-$50M2
$50M-$100M2
$100M-$250M2
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Global BioAccess Fund: United States has the largest recorded deal count among the displayed regions (6 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

Global BioAccess Fund: United States has the largest recorded deal count among the displayed regions (6 deals). All available history
RegionDeals
United States6
Europe1
Global BioAccess Fund: 20 co-investors are shown, with Alexandria Venture Investments sharing 2 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Global BioAccess Fund: 20 co-investors are shown, with Alexandria Venture Investments sharing 2 recorded deals. All available history
Co-investorShared deals
Alexandria Venture Investments2
Catalio Capital Management2
Lotte Holdings2
Norwest Venture Partners2
Novo Holdings2
8VC1
AB Magnitude Ventures Group1
abrdn1
Agent Capital1
Alpha Wave Global1
AME Cloud Ventures1
Amgen Ventures1
Amzak Health1
Andreessen Horowitz1
Aperture Venture Partners1
ARTIS Ventures1
Ascenta Capital1
B Capital Group1
Biogen1
BlackMars Capital1

Investment Strategy

Global BioAccess Fund: Led accounts for 0% and participating for 100% of round participation.All available history.
Global BioAccess Fund: Led accounts for 0% and participating for 100% of round participation. All available history
CategoryDeals (count)Share (%)
Led00%
Participating7100%
Global BioAccess Fund: Single-lead accounts for 0% and co-led for 0% of lead dynamics.All available history.
Global BioAccess Fund: Single-lead accounts for 0% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead00%
Co-led00%

Lead dynamics requires at least one led deal in this range

Team

Sonia Gulati

Principal